Mirion Technologies, Inc. (NYSE:MIR) Receives $25.56 Consensus Price Target from Brokerages

Shares of Mirion Technologies, Inc. (NYSE:MIR) have earned a consensus rating of “Moderate Buy” from the eleven analysts that are currently covering the stock, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation, eight have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year target price among analysts that have issued a report on the stock in the last year is $25.5556.

Several brokerages have commented on MIR. Weiss Ratings upgraded shares of Mirion Technologies from a “sell (d)” rating to a “hold (c)” rating in a report on Monday, August 3rd. Citigroup cut their price target on shares of Mirion Technologies from $28.00 to $24.00 and set a “buy” rating on the stock in a report on Thursday, July 30th. B. Riley Financial reduced their price target on shares of Mirion Technologies from $29.00 to $27.00 and set a “buy” rating for the company in a research report on Thursday, July 30th. Jefferies Financial Group assumed coverage on shares of Mirion Technologies in a research note on Thursday, September 3rd. They issued a “buy” rating and a $20.00 price objective for the company. Finally, Morgan Stanley lowered their price objective on shares of Mirion Technologies from $27.00 to $25.00 and set an “equal weight” rating on the stock in a research report on Monday, July 13th.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the business. Maverick Capital Ltd. purchased a new stake in Mirion Technologies in the 1st quarter worth about $49,261,000. Bank of New York Mellon Corp increased its holdings in shares of Mirion Technologies by 126.1% in the 4th quarter. Bank of New York Mellon Corp now owns 3,076,945 shares of the company’s stock valued at $72,062,000 after purchasing an additional 1,716,020 shares during the period. Stephens Investment Management Group LLC acquired a new position in shares of Mirion Technologies in the 4th quarter valued at about $18,969,000. BNP Paribas Financial Markets lifted its position in shares of Mirion Technologies by 314.9% in the fourth quarter. BNP Paribas Financial Markets now owns 904,229 shares of the company’s stock worth $21,177,000 after purchasing an additional 686,278 shares in the last quarter. Finally, Dimensional Fund Advisors LP lifted its position in shares of Mirion Technologies by 14.4% in the first quarter. Dimensional Fund Advisors LP now owns 4,694,288 shares of the company’s stock worth $87,240,000 after purchasing an additional 591,730 shares in the last quarter. 78.51% of the stock is owned by institutional investors and hedge funds.

Mirion Technologies Stock Performance

MIR opened at $15.78 on Friday. The company has a quick ratio of 2.63, a current ratio of 3.20 and a debt-to-equity ratio of 0.64. The firm has a market cap of $3.93 billion, a PE ratio of 157.75 and a beta of 1.05. The business has a fifty day simple moving average of $15.75 and a 200-day simple moving average of $17.66. Mirion Technologies has a fifty-two week low of $14.11 and a fifty-two week high of $30.28.

Mirion Technologies (NYSE:MIR) last announced its earnings results on Tuesday, July 28th. The company reported $0.12 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.10 by $0.02. The company had revenue of $266.80 million for the quarter, compared to analyst estimates of $269.32 million. Mirion Technologies had a return on equity of 6.59% and a net margin of 2.39%.Mirion Technologies’s revenue for the quarter was up 19.7% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.11 earnings per share. Mirion Technologies has set its FY 2026 guidance at 0.480-0.550 EPS. As a group, equities analysts predict that Mirion Technologies will post 0.55 EPS for the current fiscal year.

Mirion Technologies Company Profile

Mirion Technologies, Inc develops and provides radiation detection, measurement, and analysis solutions. Its products and services are used to monitor radiation, support nuclear safety, improve operational efficiency, and provide data for medical, industrial, scientific, and government applications.

The company’s offerings include radiation detectors, spectroscopy systems, dosimetry and personnel-monitoring solutions, radiation-monitoring equipment, and related software and services. In healthcare, Mirion provides technologies used in radiation therapy quality assurance, medical imaging, and radiation safety.